First Uranium to hold investor conference call on Tuesday, February 19, 2008 to discuss the quarter results



    TORONTO and JOHANNESBURG, Feb. 16 /CNW/ - First Uranium Corporation
(TSX:FIU, JSE:FUM) (ISIN:CA33744R1029) ("First Uranium" or "the Company")
today announced that the Company will conduct a conference call with investors
to discuss the Company's third quarter results and related matters at 11h00
(local Toronto time) or 18h00 (local Johannesburg time) on Tuesday,
February 19, 2008. The conference call will be available simultaneously to all
interested investors and news media in Canada and the United States at 1 800
319 4610, in South Africa at 0800 200 648 and in other countries at +1 604 638
5340 and by webcast at
http://services.choruscall.com/links/firsturanium080212.html. Listeners from
Johannesburg may also choose to call in local at +27 11 535 4600.
    A digital replay will be available for 30 days following the conference
call in Canada at 1 800 319 6413, in South Africa at +27 11 305 2030 and in
other countries at +1 604 638 9010. Callers are required to use the pin code
2128.

    About First Uranium Corporation

    First Uranium Corporation is focused on the development of South African
uranium and gold mines with the goal of becoming a significant producer
through the re-opening and development of the Ezulwini Mine, and the
construction of the Mine Waste Solutions tailings recovery facility. First
Uranium also plans to grow production by pursuing acquisition and joint
venture opportunities.





For further information:

For further information: Bob Tait, VP Investor Relations at (416)
558-3858 or bob@firsturanium.com

Organization Profile

First Uranium Corporation

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890